| Serial Number | 79267807 |
| Word Mark | KHERION |
| Filing Date | Thursday, April 4, 2019 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, July 13, 2021 |
| Registration Number | 6413425 |
| Registration Date | Tuesday, July 13, 2021 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, November 24, 2020 |
| Goods and Services | Electronic data in recorded form and downloadable electronic publications in the nature of reports, articles, e-books and e-zines relating to enzymes, vaccines, pharmaceuticals and pharmaceutical, medical and veterinary preparations and substances |
| Goods and Services | Scientific and technological services and research and design relating thereto relating to enzymes, vaccines, pharmaceuticals and pharmaceutical, medical and veterinary preparations and substances; research in the field of molecular biology; pharmaceutical, medical and veterinary research; industrial analysis in the biological, pharmaceutical, medical, and veterinary fields; industrial research services in the fields of pharmaceuticals, medicine and science; research, development, testing and evaluation of pharmaceuticals and of pharmaceutical, medical and veterinary preparations and substances; research, development, testing and evaluation of enzymes and of diagnostic agents, reagents, preparations and substances for pharmaceutical, medical and veterinary purposes; provision of information and consultancy in relation to any of the aforesaid services |
| Goods and Services | Pharmaceutical preparations for the treatment and prevention of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, cardiovascular diseases or disorders, metabolic diseases or disorders, inflammation, cancer, and diabetes; pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical, medical and veterinary preparations and substances for the treatment and prevention of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, cardiovascular diseases or disorders, metabolic diseases or disorders, inflammation, cancer, and diabetes; pharmaceutical, medical and veterinary preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases or disorders; enzymes for medical and veterinary purposes; vaccines; diagnostic agents, reagents, preparations and substances for pharmaceutical, medical and veterinary purposes; Biological preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, namely, blood fraction proteins; Biological preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases or disorders, namely, human plasma proteins; Biological preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, namely, animal plasma proteins; gene regulatory proteins for medical use; Biological preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, namely, antibodies; antibody receptors for medical use; antigens for medical use; antigen receptors for medical use; sanitary preparations for medical and veterinary purposes; preparations for destroying vermin; fungicides, herbicides; molecular components and complexes for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, October 1, 2019 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus. |
| US Class Codes | 021, 023, 026, 036, 038 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, October 1, 2019 |
| Primary Code | 009 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, October 1, 2019 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Kherion Technology Limited |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | GB |
| Party Name | Kherion Technology Limited |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | GB |
| Party Name | Kherion Technology Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | GB |
| Event Date | Event Description |
| Thursday, September 19, 2019 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Tuesday, October 1, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, October 1, 2019 | ASSIGNED TO EXAMINER |
| Saturday, October 5, 2019 | APPLICATION FILING RECEIPT MAILED |
| Tuesday, October 15, 2019 | NON-FINAL ACTION WRITTEN |
| Wednesday, October 16, 2019 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Saturday, November 2, 2019 | REFUSAL PROCESSED BY MPU |
| Saturday, November 2, 2019 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Friday, November 22, 2019 | REFUSAL PROCESSED BY IB |
| Tuesday, April 28, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, April 28, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, April 28, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, May 27, 2020 | FINAL REFUSAL WRITTEN |
| Wednesday, May 27, 2020 | FINAL REFUSAL E-MAILED |
| Wednesday, May 27, 2020 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Friday, October 16, 2020 | EXAMINERS AMENDMENT -WRITTEN |
| Friday, October 16, 2020 | EXAMINERS AMENDMENT E-MAILED |
| Friday, October 16, 2020 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Friday, October 16, 2020 | EXAMINER'S AMENDMENT ENTERED |
| Monday, October 19, 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, November 4, 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, November 4, 2020 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, November 4, 2020 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Saturday, November 21, 2020 | NOTIFICATION PROCESSED BY IB |
| Tuesday, November 24, 2020 | PUBLISHED FOR OPPOSITION |
| Tuesday, November 24, 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, November 24, 2020 | EXTENSION OF TIME TO OPPOSE RECEIVED |
| Saturday, December 12, 2020 | NOTIFICATION PROCESSED BY IB |
| Wednesday, February 24, 2021 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| Wednesday, February 24, 2021 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Saturday, March 13, 2021 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| Saturday, April 17, 2021 | NEW REPRESENTATIVE AT IB RECEIVED |
| Saturday, April 17, 2021 | LIMITATION OF GOODS RECEIVED FROM IB |
| Tuesday, April 27, 2021 | LIMITATION FROM THE IB - REQUEST EXAM REVIEW |
| Thursday, June 3, 2021 | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED |
| Tuesday, July 13, 2021 | REGISTERED-PRINCIPAL REGISTER |
| Wednesday, October 13, 2021 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Saturday, October 23, 2021 | FINAL DISPOSITION PROCESSED |
| Sunday, October 24, 2021 | FINAL DISPOSITION NOTICE SENT TO IB |
| Monday, November 15, 2021 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Monday, July 13, 2026 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |